6505--Zonisamide Capsules

SOL #: 36E79726R0005Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NAC PHARMACEUTICALS (36E797)
HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Nov 25, 2025
2
Last Updated
Mar 5, 2026
3
Submission Deadline
Dec 30, 2025, 8:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA) has awarded EXELAN PHARMACEUTICALS INC a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules, valued at $4,242,730.10. This award, made on March 5, 2026, supports pharmaceutical prime vendor programs for the VA, Department of Defense (DoD), and other government agencies.

Scope of Work

The contract covers the supply of Zonisamide Capsules in 25mg, 50mg, and 100mg strengths, 100 tablets per bottle. Key requirements include specific packaging (safety caps, compatibility with automated dispensing units, no glass bottles), unique 11-digit National Drug Code (NDC) labeling, and GS1-128 or HIBCC compliant bar coding at the unit-of-use level. Adherence to Drug Supply Chain Security Act (DSCSA) requirements, including serialized transaction information and statements using GS1 EPCIS files, is mandatory. Manufacturing facilities must maintain acceptable FDA cGMP status.

Contract Details

  • Award Number: 36E79726D0021
  • Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements
  • Period of Performance: Base year plus four one-year option periods
  • Award Value: $4,242,730.10
  • Award Date: March 5, 2026
  • Solicitation Number: 36E79726R0005
  • Awardee: EXELAN PHARMACEUTICALS INC
  • Set-Aside: Not explicitly stated (original solicitation mentioned subcontracting plan requirements for other than small businesses over $900,000)
  • NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing)
  • Product Service Code: 6505 (Drugs And Biologicals)

Distribution & Compliance

Products will be distributed through Government Pharmaceutical Prime Vendors (PPVs), requiring the awardee to establish business-to-business agreements with listed PPVs. The contract also mandates a 0.5% Cost Recovery Fee on all offered prices, quarterly sales reports, and maintenance of the same manufacturer (NDA/ANDA/BLA) for the contract duration unless approved otherwise.

Contracting Office

Department of Veterans Affairs, OPAL/National Acquisition Center, Hines, IL 60141. Point of Contact: Christopher Carthron, Christopher.Carthron@va.gov.

People

Points of Contact

Christopher CarthronContract SpecialistPRIMARY

Files

Files

Download

Versions

Version 3
Award Notice
Posted: Mar 5, 2026
View
Version 2Viewing
Solicitation
Posted: Dec 12, 2025
Version 1
Pre-Solicitation
Posted: Nov 25, 2025
View
6505--Zonisamide Capsules | GovScope